Expected RATE of Vaccine‑Associated Paralytic Poliomyelitis: A Simulation Analysis Regarding Transition from the Trivalent to Bivalent Oral Poliovirus Vaccine

Sora Yasri, Viroj Wiwanitkit

Abstract


Dear Editor,Poliomyelitis is a preventable infection by vaccine. At present, natural disease exists in some countries, especially those in Africa. The vaccine‑associated paralytic poliomyelitis(VAPP) is an unwanted adverse event of vaccination. 

Keywords


vaccine‑associated paralytic poliomyelitis; Transition; mathematical model

Full Text:

PDF

References


World Health Organization. Polio vaccines: WHO position paper, March 2016‑recommendations. Vaccine 2017;35:1197‑9.

Bahl S, Hasman A, Eltayeb AO, James Noble D, Thapa A.

The switch from trivalent to bivalent oral poliovirus vaccine in the South‑East Asia region. J Infect Dis 2017;216(Suppl_1):S94‑S100.

Chansaenroj J, Chuchaona W, Thanusuwannasak T, Duang‑In A, Puenpa J, Vutithanachot V, et al. Prevalence of poliovirus vaccine strains in randomized stool samples from 2010 to 2018: Encompassing transition from the trivalent to bivalent oral poliovirus vaccine. Virusdisease 2019;30:201‑6.

Kumthip K, Khamrin P, Maneekarn N. Detection of poliovirus

infection in children with acute gastroenteritis in Chiang Mai, Thailand. J Med Virol 2017;89:775‑81.

Kijphati R, Pongsuwanna Y, Tungcharoensilp S, Onvimol N,

Singchai P, Suwanpanyalert P. Situation of vaccine‑associated paralytic poliomyelitis case in Thailand, 2001 ‑2002. Bull Dep Med Sci 2004;46:25‑35.